nDatalyze Corp (TSE:NDAT) has released an update.
Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
nDatalyze Corp. has provided an update on its clinical study, highlighting the importance of understanding the genetic and environmental interplay in mental health issues to enhance treatment efficacy. In addition, the company’s Mindbalanced operations have adopted a franchise-style model, integrating DNA data and TMS treatments to personalize mental health care.
For further insights into TSE:NDAT stock, check out TipRanks’ Stock Analysis page.
